Dr. Justin Annes Webcast

view webcast

Dr. Annes reviewed the hPPGL Syndrome with particular focus on the underlying genetics basis and related tumor risks. He reviewed the benefits/limitations of genetic testing and pre-symptomatic screening, including his personal experience directing Stanford’s Hereditary Neuroendocrine Neoplasia Clinic. Finally, he discussed opportunities for advancing hPPGL care and ongoing research.